A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
Testosterone replacement treatment is the most effective way of treating hypogonadism in men.
Acrux has a propriety testosterone replacement product- Testosterone MD-Lotion (cutaneous
solution), and this study will evaluate the efficacy via pharmacokinetics of various doses of
this product. The study will also assess safety of the product.